WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2013> 24> 4

Volume: 24 Issue: 4

1. Management of cervical cancer patients with isolated para-aortic lymph node metastases. Page:382—383
2. The roles of ARID1A in gynecologic cancer. Page:376—381
3. Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy. Page:313—320
4. The correlates of unemployment and its association with quality of life in cervical cancer survivors. Page:367—375
5. Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study. Page:359—366
6. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture. Page:352—358
7. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. Page:342—351
8. Serum leptin, adiponectin and endometrial cancer risk in Chinese women. Page:336—341
9. Learning curve analysis of robot-assisted radical hysterectomy for cervical cancer: initial experience at a single institution. Page:303—312
10. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. Page:298—302
11. Clinical outcome of 31 patients with primary malignant melanoma of the vagina. Page:330—335
12. Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice. Page:321—329
13. Potential opportunities to reduce cervical cancer by addressing risk factors other than HPV. Page:295—297
14. Staging of ovarian cancer: time to subdivide more?. Page:293—294
15. Squamous cell carcinoma antigen in cervical cancer and beyond. Page:291—292

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.